Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

private equity corporatization business consolidation

It’s official: Radiology practice SimonMed inks partnership with New York private equity firm

The news comes days after an investment industry publication unearthed the reported $600M deal with American Securities, citing anonymous sources.

Thumbnail

Publicly traded radiology operator Akumin adds six imaging centers in $39M deal

Akumin balloons its total to 78 radiology clinics in its home state and more than 130 across the country.

mergers and acquisitions M&A puzzle

Atlanta-based Radiology Group adds docs, 67 new sites of service through recent acquisition

Following the deal, TRG now has a physical presence in 28 states while offering teleradiology care nationwide, officials said Tuesday.

Thumbnail

Cardiologist pushes for dismissal of federal lawsuit

The original lawsuit argued that the physician had engaged in "an elaborate scheme to maximize profits.”

GoodRx acquires healthcare video platform HealthiNation

GoodRx, an online source for healthcare savings and coupons, has closed its acquisition of HealthiNation, an online platform that offers thousands of videos with vital health information.

In face of COVID-19 pandemic, physician salaries remained largely unchanged

The analysis was based on data from nearly 18,000 physicians. 

M&A mergers and acquisitions business deal

Private equity firm acquiring one of nation’s largest outpatient imaging providers for $600M

Consolidation continues to spread in radiology, with American Securities reportedly reaching a deal to buy Arizona-based SimonMed, PE Hub reported.

Thumbnail

HHS rejects proposal weakening AI oversight that radvocates labeled ‘extraordinarily concerning’

The immediate-past HHS secretary's plan would have exempt many medical devices from Food and Drug Administration premarket requirements.